CD8A and neoplasm: In this regard, it has been acknowledged that TDEs harbor a plethora of membrane-bound proteins (Fas-L, PD-L1, etc.)that can directly inhibit the anti-tumor activity of effector CD8+ T cells and NK cells [7].